Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study

COVID Clinical Trial

— COMETE-19  

Official title:

Coronavirus Disease 2019 (Covid-19) at the Regional Hospital Center Metz-Thionville: a Descriptive Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04430322
• Other study ID #: 2020-02Obs-CHRMT
• Status: Completed
• Start date: March 1, 2020
• Est. completion date: June 1, 2022

Study information

• Verified date: August 2022
• Source: Centre Hospitalier Régional Metz-Thionville
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

France and especially the region "Grand Est" have been damaged by the COVID-19 pandemic. This pandemic resulted in a reorganization of the hospitalization sectors.

In order to better understand the disease, the investigators wish to carry out a descriptive analysis of hospitalized patient data. This study would notably allow us to identify some prognostic factors.

The main objective of this study is to identify individual factors that are associated with a poor prognosis (with ICU admission or death).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1045
• Est. completion date: June 1, 2022
• Est. primary completion date: June 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patient hospitalized in COVID Unit at the Regional Hospital Center Metz-Thionville during the COVID 19 pandemic

• PCR positive or COVID confirmed with clinical evidence and CT scan

Exclusion Criteria:

• Patients not willing to participate via using their medical files

• Patient transferred after a brief stay in another hospital

Related Conditions & MeSH terms

• COVID

Locations

Country	Name	City	State
France	CHR Metz Thionville	Metz

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Régional Metz-Thionville

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	ICU admission	Number of ICU admission during the hospitalization	Day 1
Secondary	Hospitalization	The duration of the hospitalization	Day 1
Secondary	Length of stay at the ICU	The duration of stay at the ICU	Day 1
Secondary	Death	The occurrence of death during the stay	Day 1
Secondary	CT scan result	Evocative CT scan result	Day 1
Secondary	C reactive protein	C reactive protein value	Day 1
Secondary	Blood Count	Blood Count value	Day 1
Secondary	Sodium	Sodium value	Day 1
Secondary	Urea	Urea value	Day 1
Secondary	Troponine	Troponine value via biological data	Day 1
Secondary	Liver function	Transaminases value	Day 1
Secondary	Coagulation test	Quick test result	Day 1
Secondary	Creatinine	creatinine value	day 1
Secondary	Clearance	creatinine clearance value	day 1
Secondary	Potassium	potassium value	day 1
Secondary	Calcium	calcium value	day 1
Secondary	Gamma-glutamyl transpeptidase	Gamma-glutamyl transpeptidase value	day 1
Secondary	Bilirubine	Bilirubine value	day 1
Secondary	Alcaline phosphatase	Alcaline phosphatase value	Day 1
Secondary	Prothrombine	Prothrombine value	Day 1